Table 6.

Deterministic analysis for the HAPO (four centres) population with NICE risk factors (n=3549)

Diagnostic threshold	Cost*	QALY*	Incremental cost	Incremental QALY	ICER
No treatment	£0	0.00	n/a	n/a	n/a
NICE 2015	£546 349	26.78	£546 349	26.78	£23 073
WHO 2013	£778 993	34.35	£254 376	7.57	£37 669

*Costs and QALYs are measured relative to a baseline of no treatment.

HAPO, Hyperglycaemia and Adverse Pregnancy Outcomes; ICER, incremental cost-effectiveness ratio; NICE, National Institute for Health and Care Excellence; QALY, quality-adjusted life year.